Acura Pharmaceuticals, a specialty pharmaceutical company engaged in research, development and manufacture of product candidates, has named Robert Jones as the company's interim president and CEO with immediate effect.
Subscribe to our email newsletter
Jones has been working with Acura Pharma since April 2008 as the senior vice president and chief operating officer.
Jones succeeds Andy Reddick, who passed away on 28 April 2011.
Prior to Acura, Jones worked as the vice president of Strategic and Business Analysis of Adolor Corporation.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.